On the Horizon – Circulating Tumor Cells in the Clinic – We are Waiting
It isn’t here yet, but it very much is here! What am I talking about? Circulating tumor cells (CTCs) are going to become a clear winner for us as the concept of using them finds [...]
PSA Doubling Time and Seminal Vesicle Invasion at the Time of Surgery Are Predictors for Successful Salvage Radiation
There was a recent Norwegian study which reviewed the impact of salvage external beam radiotherapy (EBRT) on post-prostatectomy patients. They evaluated long-term follow-up on biochemical-free recurrence (PSA only recurrence) (BFR) and metastatic-free survival. He study [...]
Measuring the Efficacy of Salvage Radiation With and Without ADT *
A small study from one hospital in Norway has suggested that PSA doubling times after surgery may predict the value of salvage radiation therapy alone as a second line form of therapy. Servoll et al [...]
On the Horizon – Bipolar Androgen Therapy
A Small study suggests that alternating testosterone levels may make hormonal therapy work longer A recent very small study was published that might lend a new light on hormone therapy for advanced prostate cancer, Bipolar [...]
Join the Malecare Survivor, Family & Friends Advisory Board
Join the Malecare Survivor, Family and Friends Advisory Board. Share your opinions and complaints about prostate cancer advocacy . Your ideas are gold, so, please join. Click here >>> Malecare Survivor Family and Friends Advisory [...]
Surprise: High-Dose Testosterone Therapy Might Help Some Men with Advanced Prostate Cancer
There has been some surprising and unexpected news recently reported by John’s Hopkins Kimmel Cancer Center. Testosterone, which is believed to be a feeder of prostate cancer has been found to also suppress some advanced [...]